Variations in radioiodine ablation: decision-making after total thyroidectomy-Reference-Cited by-同舟云学术

Variations in radioiodine ablation: decision-making after total thyroidectomy

Published:2019-11-09 Issue:3 Volume:47 Page:554-560
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Maas O.^ORCID,Forrer F.,Maas M.,Panje C. M.,Blautzik J.,Brühlmeier M.,Engel-Bicik I.,Giovanella L.,Haldemann A.,Kamel M. E.,Kneifel S.,Rottenburger C.,Schaefer N.,Walter M. A.,Weidner S.,Putora P. M.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-019-04557-4.pdf

Reference33 articles.

1. Haugen BR, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133.

2. Hay ID. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol. 2006;94(8):692–700.

3. Hay ID, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008;144(6):980–8.

4. Gerstein HC, et al. A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab. 2004;89(8):3668–76.

5. Sacks W, et al. The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008. Thyroid. 2010;20(11):1235–45.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real Life Study;Cancers;2023-04-22

2. Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer;Archives of Endocrinology and Metabolism;2023-01-18

3. Nuclear medicine therapy of thyroid cancer post-thyroidectomy;Nuclear Medicine and Molecular Imaging;2022

4. Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy;Oncology;2021-11-17

5. Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer;European Journal of Endocrinology;2021-09-01